Aemetis (NASDAQ:AMTX) Shares Pass Below 200-Day Moving Average of $7.33

Aemetis, Inc. (NASDAQ:AMTXGet Rating)’s share price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $7.33 and traded as low as $5.97. Aemetis shares last traded at $6.28, with a volume of 680,565 shares changing hands.

Analyst Upgrades and Downgrades

AMTX has been the topic of a number of research analyst reports. StockNews.com raised shares of Aemetis to a “sell” rating in a research report on Thursday, October 27th. Truist Financial reduced their target price on shares of Aemetis to $9.00 in a research report on Friday, November 4th.

Aemetis Trading Up 4.8 %

The company’s 50 day moving average price is $7.06 and its two-hundred day moving average price is $7.33. The stock has a market cap of $220.08 million, a P/E ratio of -2.42 and a beta of 0.83.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of AMTX. Allspring Global Investments Holdings LLC bought a new position in shares of Aemetis during the 1st quarter valued at approximately $26,000. JPMorgan Chase & Co. lifted its position in shares of Aemetis by 16.0% during the first quarter. JPMorgan Chase & Co. now owns 16,362 shares of the specialty chemicals company’s stock worth $208,000 after purchasing an additional 2,256 shares during the last quarter. L & S Advisors Inc lifted its position in shares of Aemetis by 42.6% during the first quarter. L & S Advisors Inc now owns 138,404 shares of the specialty chemicals company’s stock worth $1,754,000 after purchasing an additional 41,316 shares during the last quarter. Raymond James & Associates lifted its position in shares of Aemetis by 64.4% during the first quarter. Raymond James & Associates now owns 18,120 shares of the specialty chemicals company’s stock worth $230,000 after purchasing an additional 7,097 shares during the last quarter. Finally, Citigroup Inc. increased its stake in shares of Aemetis by 15.0% during the first quarter. Citigroup Inc. now owns 50,504 shares of the specialty chemicals company’s stock valued at $640,000 after buying an additional 6,603 shares during the period. 51.91% of the stock is currently owned by institutional investors.

About Aemetis

(Get Rating)

Aemetis, Inc operates as a renewable natural gas and renewable fuels company in North America and India. It operates through three segments: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products.

Featured Articles

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.